Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples